Target Controlled Infusion of Intravenous Propofol versus Target Controlled Infusion of Dexmedetomidine for sedation of Recipient post Liver transplant.

The Target Controlled Infusion of Intravenous Propofol versus Target Controlled Infusion of Dexmedetomidine for sedation of Recipient post Liver transplant surgery: A comparative study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202503518380400

Enrollment

Registered

2025-03-14

Start date

2024-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

propofol group

dexmedetomidine group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patient aged from 18 to 65 years old undergoing liver transplant

Exclusion criteria

Exclusion criteria: * Patient with severe cardiovascular disease. * History of neurological insult. Allergy to propofol. * Severe hemodynamic instability. * Prolonged need for Mechanical Ventilation. * patients who treated with drugs affecting the heart rate.

Design outcomes

Primary

Measure	Time frame
Mean arterial blood pressure (MABP) in recipient patient receiving sedation by propofol versus dexmedetomidine post liver transplant	—

Secondary

Measure	Time frame
the analgesic requirement, time for weaning from MV, ICU stay and the economic cost	—

Countries

Egypt

Contacts

Public Contacthanaa rashed

lecturer of anasthesia

hanaarashed2020@yahoo.com01001378542

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 10, 2026